(Q39099624)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

title

Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

1 reference

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

author name string

F Conti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

S Brillanti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

F Buonfiglioli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

R Vukotic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

M C Morelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

C Lalanne

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

M Massari

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

F G Foschi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

V Bernabucci

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

I Serio

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

G M Prati

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

E Negri

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

L Badia

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

P Caraceni

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

P Muratori

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

G Vitale

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

A Porro

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

M Morotti

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

P Andreone

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

language of work or name

1 reference

2 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

Journal of Viral Hepatitis

29 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

page(s)

454-463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?

29 March 2020

cites work

1 reference

Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention

21 January 2018

1 reference

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

21 January 2018

1 reference

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

21 January 2018

1 reference

A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus

21 January 2018

1 reference

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

21 January 2018

1 reference

Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population

21 January 2018

1 reference

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C.

21 January 2018

1 reference

Age and prediction of sustained virological response to hepatitis C virus (HCV) infection treatment based on 28-day decrease in HCV RNA levels

21 January 2018

1 reference

Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C.

21 January 2018

1 reference

21 January 2018

1 reference

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

21 January 2018

1 reference

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

21 January 2018

1 reference

Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

21 January 2018

1 reference

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

21 January 2018

1 reference

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis

21 January 2018

1 reference

ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.

21 January 2018

1 reference

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study

21 January 2018

1 reference

Hepatitis C Infection in the Elderly

21 January 2018

1 reference

Cost-effectiveness of novel regimens for the treatment of hepatitis C virus

21 January 2018

1 reference

Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

1 reference

Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients

21 January 2018

1 reference

Patient-Reported Outcomes of Elderly Adults with Chronic Hepatitis C Treated with Interferon- and Ribavirin-Free Regimens

21 January 2018

1 reference

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study

21 January 2018

1 reference

Prevalence of antibodies against hepatitis C virus in the elderly: a seroepidemiological study in a nursing home and in an open population. The Collaborative Group

21 January 2018

1 reference

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy

21 January 2018

1 reference

Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older

21 January 2018

1 reference

Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver

21 January 2018

1 reference

The efficacy and safety of direct acting antiviral treatment and clinical significance of drug-drug interactions in elderly patients with chronic hepatitis C virus infection

21 January 2018

1 reference

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

21 January 2018

1 reference

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study

21 January 2018

1 reference

Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection.

21 January 2018

1 reference

Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis

21 January 2018

1 reference

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

21 January 2018

1 reference

Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis.

21 January 2018

1 reference

Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus

21 January 2018

1 reference

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

21 January 2018

1 reference

Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

21 January 2018

1 reference

Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JVH.12663

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27976461%20AND%20SRC:MED&resulttype=core&format=json

release_7g25xrm6azdtnnkydyhcvm2kje

29 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7g25xrm6azdtnnkydyhcvm2kje

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference